Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Change in Acquisitions & Divestments (2020 - 2025)

Historic Change in Acquisitions & Divestments for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Q3 2025 value amounting to $18.8 million.

  • Mirum Pharmaceuticals' Change in Acquisitions & Divestments rose 14283.87% to $18.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.5 million, marking a year-over-year increase of 58335.81%. This contributed to the annual value of $19.9 million for FY2024, which is 8699.74% down from last year.
  • According to the latest figures from Q3 2025, Mirum Pharmaceuticals' Change in Acquisitions & Divestments is $18.8 million, which was up 14283.87% from $25.1 million recorded in Q2 2025.
  • Over the past 5 years, Mirum Pharmaceuticals' Change in Acquisitions & Divestments peaked at $64.5 million during Q1 2023, and registered a low of $3.0 million during Q4 2023.
  • Moreover, its 5-year median value for Change in Acquisitions & Divestments was $30.0 million (2023), whereas its average is $31.2 million.
  • As far as peak fluctuations go, Mirum Pharmaceuticals' Change in Acquisitions & Divestments surged by 40000.0% in 2021, and later tumbled by 8888.89% in 2023.
  • Quarter analysis of 5 years shows Mirum Pharmaceuticals' Change in Acquisitions & Divestments stood at $38.0 million in 2021, then fell by 28.95% to $27.0 million in 2022, then plummeted by 88.89% to $3.0 million in 2023, then skyrocketed by 304.8% to $12.1 million in 2024, then surged by 54.97% to $18.8 million in 2025.
  • Its Change in Acquisitions & Divestments was $18.8 million in Q3 2025, compared to $25.1 million in Q2 2025 and $17.4 million in Q1 2025.